The Department of Health and Human Services has awarded a $6 million contract to further develop a novel diagnostics technology to rapidly distinguish bacterial infections from viral infections. “Rapid diagnostics are a cornerstone of our strategy to protect Americans from many bacterial and viral infections; earlier diagnosis can empower patients to take action to reduce disease transmission,” said Rick Bright, director of HHS’s Biomedical Advanced Research and Development Authority. “Antimicrobial resistance is a growing threat to public health and the health security of the United States, and diagnostics that can provide rapid results to patients and doctors will support stewardship of antibiotics and save lives.”

Related News Articles

Headline
The Department of Health and Human Services today announced a $226 million contract to expand the nation’s capacity to quickly produce vaccine for a flu…
Headline
Acute-care hospitals reduced Clostridium difficile infections by 12%, central line-associated bloodstream infections by 9% and catheter-associated urinary…
Headline
The Centers for Disease Control and Prevention Friday released an update to its 1998 guidelines to prevent and control infection in the health care workplace,…
Chairperson's File
“Get vaccinated” is a message everyone should hear, and hospitals and health systems are the ideal partners to spread it.
Headline
Only one in three U.S. pregnant women receive both the flu and whooping cough vaccines as recommended, according to a Vital Signs report released today by the…
Headline
The U.S. has retained its measles elimination status for another year, the Department of Health and Human Services announced Friday.